First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
Santosh KumaraswamyIndian Journal of Urology 2021 37(3):295-296
Source: Indian Journal of Urology - Category: Urology & Nephrology Authors: Santosh Kumaraswamy Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Immunotherapy | India Health | Urology & Nephrology